Nutrient transitions are a source of persisters in Escherichia coli biofilms

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Amato, Stephanie M ^a   Brynildsen, Mark P ^a  

^a Princeton University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; NUCLEOID ASSOCIATED PROTEIN; PPGPP SYNTHASE; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ARTICLE; BIOFILM; CARBON SOURCE; CONTROLLED STUDY; ESCHERICHIA COLI; NONHUMAN; NUTRIENT AVAILABILITY;

BIOFILMS; CARBON; CULTURE TECHNIQUES; ESCHERICHIA COLI; LIGASES; TRANSCRIPTION FACTOR RELA;

EID: 84899731866     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093110     Document Type: Article

References (65)

1. Kint CI, Verstraeten N, Fauvart M, Michiels J (2012) New-found fundamentals of bacterial persistence. Trends Microbiol 20: 577-585.
2. Lewis K (2007) Persister cells, dormancy and infectious disease. Nat Rev Microbiol 5: 48-56.
3. Fauvart M, De Groote VN, Michiels J (2011) Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. J Med Microbiol 60: 699-709.
4. Maisonneuve E, Castro-Camargo M, Gerdes K (2013) (p)ppGpp Controls Bacterial Persistence by Stochastic Induction of Toxin-Antitoxin Activity. Cell 154: 1140-1150.
5. Nguyen D, Joshi-Datar A, Lepine F, Bauerle E, Olakanmi O, et al. (2011) Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 334: 982-986.
6. Bernier SP, Lebeaux D, DeFrancesco AS, Valomon A, Soubigou G, et al. (2013) Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin. PLoS Genet 9: e1003144.
7. Harrison JJ, Wade WD, Akierman S, Vacchi-Suzzi C, Stremick CA, et al. (2009) The chromosomal toxin gene yafQ is a determinant of multidrug tolerance for Escherichia coli growing in a biofilm. Antimicrob Agents Chemother 53: 2253-2258.
8. Fasani RA, Savageau MA (2013) Molecular mechanisms of multiple toxinantitoxin systems are coordinated to govern the persister phenotype. Proc Natl Acad Sci U S A 110: E2528-2537.
9. Klumpp S, Zhang Z, Hwa T (2009) Growth rate-dependent global effects on gene expression in bacteria. Cell 139: 1366-1375.
10. Orman MA, Brynildsen MP (2013) Dormancy is not necessary or sufficient for bacterial persistence. Antimicrob Agents Chemother 57: 3230-3239.
11. Moker N, Dean CR, Tao J (2010) Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules. J Bacteriol 192: 1946-1955.
12. Vega NM, Allison KR, Khalil AS, Collins JJ (2012) Signaling-mediated bacterial persister formation. Nat Chem Biol 8: 431-433.
13. Boles BR, Singh PK (2008) Endogenous oxidative stress produces diversity and adaptability in biofilm communities. Proc Natl Acad Sci U S A 105: 12503-12508.
14. Wu Y, Vulic M, Keren I, Lewis K (2012) Role of Oxidative Stress in Persister Tolerance. Antimicrob Agents Chemother.
15. Walters MC, 3rd, Roe F, Bugnicourt A, Franklin MJ, Stewart PS (2003) Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 47: 317-323. (Pubitemid 36070381)
16. Amato Stephanie M, Orman Mehmet A, Brynildsen Mark P (2013) Metabolic Control of Persister Formation in Escherichia coli. Mol Cell 50: 475-487.
17. Allison KR, Brynildsen MP, Collins JJ (2011) Heterogeneous bacterial persisters and engineering approaches to eliminate them. Curr Opin Microbiol 14: 593-598.
18. Li Y, Zhang Y (2007) PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli. Antimicrob Agents Chemother 51: 2092-2099. (Pubitemid 46903099)
19. Ma C, Sim S, Shi W, Du L, Xing D, et al. (2010) Energy production genes sucB and ubiF are involved in persister survival and tolerance to multiple antibiotics and stresses in Escherichia coli. FEMS Microbiol Lett 303: 33-40.
20. Williamson KS, Richards LA, Perez-Osorio AC, Pitts B, McInnerney K, et al. (2012) Heterogeneity in Pseudomonas aeruginosa biofilms includes expression of ribosome hibernation factors in the antibiotic-tolerant subpopulation and hypoxia-induced stress response in the metabolically active population. J Bacteriol 194: 2062-2073.
21. Dorr T, Vulic M, Lewis K (2010) Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol 8: e1000317.
22. Dame RT, Kalmykowa OJ, Grainger DC (2011) Chromosomal macrodomains and associated proteins: implications for DNA organization and replication in gram negative bacteria. PLoS Genet 7: e1002123.
23. Dillon SC, Dorman CJ (2010) Bacterial nucleoid-associated proteins, nucleoid structure and gene expression. Nat Rev Microbiol 8: 185-195.
24. Bujard H, Gentz R, Lanzer M, Stueber D, Mueller M, et al. (1987) A T5 promoter-based transcription-translation system for the analysis of proteins in vitro and in vivo. Methods Enzymol 155: 416-433.
25. Lewis K (2010) Persister cells. Annu Rev Microbiol 64: 357-372.
26. Dhar N, McKinney JD (2007) Microbial phenotypic heterogeneity and antibiotic tolerance. Curr Opin Microbiol 10: 30-38. (Pubitemid 46216877)
27. Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S (2004) Bacterial persistence as a phenotypic switch. Science 305: 1622-1625. (Pubitemid 39296357)
28. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ (2007) A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130: 797-810. (Pubitemid 47332566)
29. Monod J (1942) Recherches sur la croissance des cultures bacteriennes. 2nd Ed..
30. Roseman S, Meadow ND (1990) Signal transduction by the bacterial phosphotransferase system. Diauxie and the crr gene (J. Monod revisited). J Biol Chem 265: 2993-2996.
31. Narang A, Pilyugin SS (2007) Bacterial gene regulation in diauxic and nondiauxic growth. J Theor Biol 244: 326-348. (Pubitemid 44779642)
32. Coenye T, Nelis HJ (2010) In vitro and in vivo model systems to study microbial biofilm formation. J Microbiol Methods 83: 89-105.
33. Harrison JJ, Turner RJ, Ceri H (2005) High-throughput metal susceptibility testing of microbial biofilms. BMC Microbiol 5: 53.
34. Zuroff TR, Bernstein H, Lloyd-Randolfi J, Jimenez-Taracido L, Stewart PS, et al. (2010) Robustness analysis of culturing perturbations on Escherichia coli colony biofilm beta-lactam and aminoglycoside antibiotic tolerance. BMC Microbiol 10: 185.
35. Saier MH, Ramseier T.M., Reizer J. (1996) Regulation of Carbon Utilization. Escherichia coli and Salmonella: cellular and molecular biology, 2nd Ed. Washington D.C.: ASM Press.
36. Clark B, Holms WH (1976) Control of the sequential utilization of glucose and fructose by Escherichia coli. J Gen Microbiol 96: 191-201.
37. Bachi B, Kornberg HL (1975) Utilization of gluconate by Escherichia coli. A role of adenosine 3':5'-cyclic monophosphate in the induction of gluconate catabolism. Biochem J 150: 123-128.
38. Allison KR, Brynildsen MP, Collins JJ (2011) Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473: 216-220.
39. Orman MA, Brynildsen MP (2013) Establishment of a method to rapidly assay bacterial persister metabolism. Antimicrob Agents Chemother 57: 4398-4409.
40. Traxler MF, Chang DE, Conway T (2006) Guanosine 3',5'-bispyrophosphate coordinates global gene expression during glucose-lactose diauxie in Escherichia coli. Proc Natl Acad Sci U S A 103: 2374-2379. (Pubitemid 43271677)
41. Potrykus K, Cashel M (2008) (p)ppGpp: still magical? Annu Rev Microbiol 62: 35-51.
42. Xiao H, Kalman M, Ikehara K, Zemel S, Glaser G, et al. (1991) Residual guanosine 3',5'-bispyrophosphate synthetic activity of relA null mutants can be eliminated by spoT null mutations. J Biol Chem 266: 5980-5990. (Pubitemid 21909592)
43. Dalebroux ZD, Swanson MS (2012) ppGpp: magic beyond RNA polymerase. Nat Rev Microbiol 10: 203-212.
44. An G, Justesen J, Watson RJ, Friesen JD (1979) Cloning the spoT gene of Escherichia coli: identification of the spoT gene product. J Bacteriol 137: 1100-1110. (Pubitemid 9198874)
45. Potrykus K, Murphy H, Philippe N, Cashel M (2011) ppGpp is the major source of growth rate control in E. coli. Environ Microbiol 13: 563-575.
46. Kolmsee T, Delic D, Agyenim T, Calles C, Wagner R (2011) Differential stringent control of Escherichia coli rRNA promoters: effects of ppGpp, DksA and the initiating nucleotides. Microbiology 157: 2871-2879.
47. Baracchini E, Bremer H (1988) Stringent and growth control of rRNA synthesis in Escherichia coli are both mediated by ppGpp. J Biol Chem 263: 2597-2602. (Pubitemid 18062897)
48. Ryals J, Little R, Bremer H (1982) Control of rRNA and tRNA syntheses in Escherichia coli by guanosine tetraphosphate. J Bacteriol 151: 1261-1268. (Pubitemid 13243091)
49. Durfee T, Hansen AM, Zhi H, Blattner FR, Jin DJ (2008) Transcription profiling of the stringent response in Escherichia coli. J Bacteriol 190: 1084-1096. (Pubitemid 351170952)
50. Ferullo DJ, Lovett ST (2008) The stringent response and cell cycle arrest in Escherichia coli. PLoS Genet 4: e1000300.
51. Maxwell A (1997) DNA gyrase as a drug target. Trends Microbiol 5: 102-109.
52. Ferullo DJ, Lovett S.T. (2008) The Stringent Response and Cell Cycle Arrest in Escherichia coli. PLoS Genetics: 1-15.
53. Travers A, Muskhelishvili G (2005) DNA supercoiling - a global transcriptional regulator for enterobacterial growth? Nat Rev Microbiol 3: 157-169. (Pubitemid 40207596)
54. Ninnemann O, Koch C, Kahmann R (1992) The E.coli fis promoter is subject to stringent control and autoregulation. EMBO J 11: 1075-1083.
55. Claret L, Rouviere-Yaniv J (1996) Regulation of HU alpha and HU beta by CRP and FIS in Escherichia coli. J Mol Biol 263: 126-139. (Pubitemid 26363077)
56. Lee H, Kim HK, Kang S, Hong CB, Yim J, et al. (2001) Expression of the seqA gene is negatively modulated by the HU protein in Escherichia coli. Mol Gen Genet 264: 931-935.
57. Mott ML, Berger JM (2007) DNA replication initiation: mechanisms and regulation in bacteria. Nat Rev Microbiol 5: 343-354. (Pubitemid 46605488)
58. Ali Azam T, Iwata A, Nishimura A, Ueda S, Ishihama A (1999) Growth phase-dependent variation in protein composition of the Escherichia coli nucleoid. J Bacteriol 181: 6361-6370. (Pubitemid 29512946)
59. Kang S, Han JS, Park JH, Skarstad K, Hwang DS (2003) SeqA protein stimulates the relaxing and decatenating activities of topoisomerase IV. J Biol Chem 278: 48779-48785. (Pubitemid 41079520)
60. Dorman CJ (1991) DNA supercoiling and environmental regulation of gene expression in pathogenic bacteria. Infect Immun 59: 745-749.
61. Dorman CJ, Barr GC, Ni Bhriain N, Higgins CF (1988) DNA supercoiling and the anaerobic and growth phase regulation of tonB gene expression. J Bacteriol 170: 2816-2826.
62. Pruss BM, Nelms JM, Park C, Wolfe AJ (1994) Mutations in NADH:ubiquinone oxidoreductase of Escherichia coli affect growth on mixed amino acids. J Bacteriol 176: 2143-2150.
63. Lewis K (2008) Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol 322: 107-131.
64. Korch SB, Henderson TA, Hill TM (2003) Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesis. Mol Microbiol 50: 1199-1213. (Pubitemid 37475853)
65. Wexselblatt E, Oppenheimer-Shaanan Y, Kaspy I, London N, Schueler-Furman O, et al. (2012) Relacin, a novel antibacterial agent targeting the Stringent Response. PLoS Pathog 8: e1002925.